Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Thierry Schmitz"'
Autor:
Vjera Grabovac, Martin H. Hoffer, Andreas Bernkop-Schnürch, Thomas F. Palmberger, Thierry Schmitz
Publikováno v:
International Journal of Pharmaceutics. 347:79-85
The aim of the present study was to synthesize and characterize a novel thiolated polymer by covalent attachment of N-acetyl cysteine to chitosan. The obtained conjugate was characterized in vitro by quantification of immobilized thiol groups and the
Publikováno v:
Drug Delivery. 15:245-252
This study evaluated three chitosan-N-acetyl cysteine (CAC) conjugates of increasing molecular mass as a valuable tool to improve the absorption of drugs by assessing its permeation enhancing effect regarding the active P-gp substrate rhodamine-123 i
Autor:
Andreas Bernkop-Schnürch, Christine Vauthier, Gilles Ponchel, Thierry Schmitz, Irene Bravo-Osuna
Publikováno v:
International Journal of Pharmaceutics. 316:170-175
The aim of the present work was to investigate the use of thiolated chitosan in the development of polysaccharide-coated nanoparticles in order to confer specific functionality to the system. After chemical modification of commercial and hydrolysed c
Publikováno v:
Journal of Drug Targeting. 14:117-125
In oral peptide delivery, the gap between convenient administration and low blood concentration has to be minimized. We found that oral peptide drugs have not only to pass the various commonly known barriers encountered with the gastrointestinal trac
Publikováno v:
Amino Acids. 30:35-42
To date, the majority of therapeutic peptides and proteins have to be administered via parenteral routes, which are painful and inconvenient. In order to gain sufficient high blood concentrations after oral application, various barriers in the gastro
Publikováno v:
Journal of Pharmaceutical Sciences. 94:966-973
Low molecular weight heparin (LMWH) is an agent of choice in the anti-coagulant therapy and prophylaxis of thrombosis and coronary syndromes. However, the therapeutic use is partially limited due to a poor oral bioavailability. It was therefore the a
Publikováno v:
Current drug metabolism. 8(5)
To date, the majority of therapeutic peptides and proteins have to be administered via parenteral routes, which are painful and inconvenient. Consequently, "injectable-to-oral-conversions" are highly on demand. Apart from a poor membrane uptake, howe
Publikováno v:
Pharmaceutical research. 24(5)
The purpose of this study was to evaluate an effect of the proteolytic enzyme papain on permeation of low molecular weight heparin (LMWH) in vitro and in vivo.In vitro permeation studies were performed using rat small intestine as permeation barrier.
Autor:
Andreas Bernkop-Schnürch, Hong-Lei Huang, Thierry Schmitz, Martin Werle, Alexander Wentzel, Harald Kolmar
Publikováno v:
Journal of drug targeting. 14(3)
Within this study, the potential of three clinically relevant microproteins (SE-AG-AZ, SE-EM and SE-EP) with cystine-knot architecture as pharmacophoric scaffolds for oral peptide delivery was investigated. Cystine-knot microproteins (CKM) were analy
Autor:
Thierry Schmitz, Andreas Bernkop-Schnürch, Christine Vauthier, Brigitta Loretz, Irene Bravo-Osuna, Gilles Ponchel
Publikováno v:
Biomaterials. 28(3)
Chitosan-thiobutylamidine was developed and evaluated as a novel tool for gene delivery. The conjugate, displaying 299.1+/-11.5 micromol free thiol groups per gram polymer, formed coacervates with pDNA at a mean size of 125 nm and a zeta potential of